These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3031 related articles for article (PubMed ID: 776445)

  • 41. Immunotherapy in acute leukemias. Possible applications in children.
    Mahoney DH; Starling KA
    Am J Pediatr Hematol Oncol; 1981; 3(4):410-8. PubMed ID: 7036781
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Transplant of autologous bone marrow: indications and results].
    Bernasconi C; Alessandrino P
    Riv Emoter Immunoematol; 1985; 32(1):1-16. PubMed ID: 3909360
    [No Abstract]   [Full Text] [Related]  

  • 43. [Immunology: access route to the treatment of cancer].
    Mathe G; Amiel JL; Schwarzenberg L; Schneider M; Berumen L; Jasmin C
    Gac Med Mex; 1971 Jun; 101(6):707-30. PubMed ID: 4935063
    [No Abstract]   [Full Text] [Related]  

  • 44. The application of immunotherapy to the treatment of cancer.
    Powles RL
    Pharmacol Ther; 1979; 4(2):281-306. PubMed ID: 386383
    [No Abstract]   [Full Text] [Related]  

  • 45. European experience of bone marrow transplantation for leukemia.
    Ringdén O; Zwaan F; Hermans J; Gratwohl A
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2600-4. PubMed ID: 3547941
    [No Abstract]   [Full Text] [Related]  

  • 46. [Bone marrow transplantation in humans. I. Transplantation in acute and chronic leukemia].
    Izzi T; Gale PG; Lucarelli G
    Recenti Prog Med; 1982 Feb; 72(2):213-28. PubMed ID: 7048459
    [No Abstract]   [Full Text] [Related]  

  • 47. Therapeutic applications of allogeneic BMT: aplastic anemia and the leukemias.
    Oblon DJ; Weiner RS; Mackin PJ
    J Fla Med Assoc; 1984 May; 71(5):329-35. PubMed ID: 6376696
    [No Abstract]   [Full Text] [Related]  

  • 48. [Immunotherapy of cancer with BCG].
    Rieche K; Schneeweiss U; Gummel H
    Dtsch Gesundheitsw; 1970 Aug; 25(34):1581-5. PubMed ID: 4926378
    [No Abstract]   [Full Text] [Related]  

  • 49. [Substitution with immunoglobulins in leukemia].
    Schmitz N; Gassmann W; Löffler H
    Beitr Infusionther Klin Ernahr; 1982; 9():25-33. PubMed ID: 6756384
    [No Abstract]   [Full Text] [Related]  

  • 50. The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML.
    Redaelli A; Stephens JM; Laskin BL; Pashos CL; Botteman MF
    Expert Rev Anticancer Ther; 2003 Jun; 3(3):311-29. PubMed ID: 12820775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Immunotherapy of leukemia--a realistic clinical possibility?].
    Gahrton G
    Lakartidningen; 1971 Mar; 68(14):1601-8. PubMed ID: 4930453
    [No Abstract]   [Full Text] [Related]  

  • 52. Immune complexes in children with leukemia: relationship to disease characteristics and to antibody response to Mycobacterium bovis (BCG) in patients receiving BCG immunotherapy.
    Minden P; Odom LF; Tubergen DG; Hardtke MA; Sharpton TR; Rose B; Zlotnick A; Carr RI
    Cancer; 1980 Feb; 45(3):460-8. PubMed ID: 6986198
    [No Abstract]   [Full Text] [Related]  

  • 53. [Immunotherapy of leukemia].
    Amiel JL
    Brux Med; 1970 Mar; 50(3):185-94. PubMed ID: 5267258
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunotherapy with cultured human cells and BCG.
    Sokal JE; Aungst CW
    Transplant Proc; 1975 Jun; 7(2):317-21. PubMed ID: 1093299
    [No Abstract]   [Full Text] [Related]  

  • 55. BCG in cancer and leukemia treatment and prophylaxis-A review.
    Rosenthal SR
    J Med; 1975; 6(3-4):193-212. PubMed ID: 1104732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interferon-alpha: current status and future promise.
    Bonnem EM; Spiegel RJ
    J Biol Response Mod; 1984 Dec; 3(6):580-98. PubMed ID: 6392483
    [No Abstract]   [Full Text] [Related]  

  • 57. Management of childhood acute leukaemia.
    Fennelly JJ; McBride A; O'Donoghue S; Kavanagh TM; Cahalane S
    Ir Med J; 1974 Nov; 67(22):589-94. PubMed ID: 4533268
    [No Abstract]   [Full Text] [Related]  

  • 58. Experience with bone marrow transplantation for severe aplastic anemia and leukemia. Two years experience with 31 patients in Zagreb (Yugoslavia).
    Labar B; Bogdanic V; Kastelan A; Vrtar M; Grgic-Markulin L; Balabanic-Kamauf B; Francetic I; Dobric I; Grgicevic D; Kerhin-Brkljacic V
    Biomed Pharmacother; 1986; 40(9):332-7. PubMed ID: 3548836
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunotherapy in previously treated acute lymphatic leukemia.
    Leventhal BG; LePourhiet A; Halterman RH; Henderson ES; Herberman RB
    Natl Cancer Inst Monogr; 1973 Dec; 39():177-87. PubMed ID: 4274495
    [No Abstract]   [Full Text] [Related]  

  • 60. Transplantation of T lymphocyte depleted bone marrow to prevent graft-versus-host disease: its implications for fetal liver transplantation.
    Champlin RE; Mitsuyasu RT; Gale RP
    Prog Clin Biol Res; 1985; 193():315-25. PubMed ID: 3911215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 152.